Published in J Clin Invest on February 01, 1994
Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A (1997) 1.80
Endothelium and its alterations in cardiovascular diseases: life style intervention. Biomed Res Int (2014) 1.03
Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest (1995) 0.96
Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein. J Clin Invest (1995) 0.93
Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest (1996) 0.93
Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings. Br J Pharmacol (1999) 0.92
Mitochondria: a pathogenic paradigm in hypertensive renal disease. Hypertension (2014) 0.88
Nitric oxide function in atherosclerosis. Mediators Inflamm (1997) 0.87
Antioxidants: the good, the bad and the ugly. Can J Cardiol (2006) 0.87
Differential effects of topical vitamin E and C E Ferulic® treatments on ultraviolet light B-induced cutaneous tumor development in Skh-1 mice. PLoS One (2013) 0.85
Role of Advanced Glycation End Products and Its Receptors in the Pathogenesis of Cigarette Smoke-Induced Cardiovascular Disease. Int J Angiol (2015) 0.84
Regulatory metabolites of vitamin E and their putative relevance for atherogenesis. Redox Biol (2014) 0.83
Lipoic acid supplementation and endothelial function. Br J Pharmacol (2008) 0.81
Impaired graft healing due to hypercholesterolemia is prevented by dietary supplementation with alpha-tocopherol. J Vasc Surg (2008) 0.79
Antioxidant properties of Berberis aetnensis C. Presl (Berberidaceae) roots extract and protective effects on astroglial cell cultures. ScientificWorldJournal (2014) 0.77
Tocopherol induced angiogenesis in placental vascular network in late pregnant ewes. Reprod Biol Endocrinol (2010) 0.77
Why do antioxidants fail to provide clinical benefit? Curr Control Trials Cardiovasc Med (2000) 0.77
Dietary antioxidants, cancer, and atherosclerotic heart disease. West J Med (1994) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Enzymatic determination of total serum cholesterol. Clin Chem (1974) 20.65
Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A (1990) 16.34
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med (1989) 15.67
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A (1987) 14.22
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (1986) 9.93
Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem (1973) 8.51
Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A (1981) 8.45
Biochemistry of nitric oxide and its redox-activated forms. Science (1992) 7.72
Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest (1991) 6.50
Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A (1984) 6.01
Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39
Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest (1993) 4.70
Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature (1990) 4.28
Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A (1989) 4.02
Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol (1986) 3.66
Control of coronary vascular tone by nitric oxide. Circ Res (1990) 3.64
Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A (1987) 3.55
Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet (1991) 3.29
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation (1990) 3.20
Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest (1991) 3.07
Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res (1983) 2.85
Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun (1989) 2.81
Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest (1987) 2.48
Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature (1990) 2.46
Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest (1986) 2.38
Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A (1991) 2.34
Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest (1990) 1.99
Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys (1983) 1.99
Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res (1991) 1.83
Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc Natl Acad Sci U S A (1993) 1.83
Reaction of NO with O2-. implications for the action of endothelium-derived relaxing factor (EDRF). Free Radic Res Commun (1990) 1.57
Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest (1992) 1.49
Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clin Chem (1983) 1.45
Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem J (1992) 1.43
Single vertical spin density gradient ultracentrifugation. Methods Enzymol (1986) 1.36
Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100. Proc Natl Acad Sci U S A (1990) 1.28
Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J Lipid Res (1989) 1.28
Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun (1990) 1.13
Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem (1993) 1.12
Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res (1991) 1.11
Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells. Circ Res (1992) 0.99
Low plasma vitamins E and C. Increased risk of angina in Scottish men. Ann N Y Acad Sci (1989) 0.94
Loss of alpha-tocopherol upon exposure to nitric oxide or the sydnonimine SIN-1. FEBS Lett (1993) 0.92
Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res (1993) 0.91
Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative. J Clin Invest (1992) 0.89
Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis (1992) 0.87
Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E. Br J Nutr (1989) 0.82
Vitamin E, antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits. J Nutr (1978) 0.81
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature (1993) 8.29
Biochemistry of nitric oxide and its redox-activated forms. Science (1992) 7.72
Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70
Homocysteine and atherothrombosis. N Engl J Med (1998) 6.70
Medicinal plants in Mexico: healers' consensus and cultural importance. Soc Sci Med (1998) 5.51
S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A (1992) 5.37
Treatment of hypertension with ascorbic acid. Lancet (1999) 4.74
Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA (1997) 4.37
Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol (2000) 4.21
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A (1992) 3.72
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med (1995) 3.60
Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med (1999) 3.21
Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet (1998) 3.06
The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med (1994) 2.90
Antioxidants and atherosclerotic heart disease. N Engl J Med (1997) 2.86
The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med (1991) 2.74
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest (1990) 2.69
Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr (2001) 2.64
The platelet function defect of cardiopulmonary bypass. Blood (1993) 2.63
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology (2011) 2.52
Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials. N Engl J Med (1996) 2.48
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest (1993) 2.47
Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A (1991) 2.34
Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation (1996) 2.28
Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc Natl Acad Sci U S A (1999) 2.27
Aspirin. Circulation (2000) 2.26
Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med (1995) 2.26
Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension (2000) 2.23
A noninvasive method of predicting pulmonary-capillary wedge pressure. N Engl J Med (1992) 2.12
The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc (1999) 2.12
Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature (1987) 2.04
Migraine, headache, and the risk of stroke in women: a prospective study. Neurology (2005) 2.01
Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr (1999) 1.97
Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest (2000) 1.94
Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J (1999) 1.94
Clinical clues to the cause of Addison's disease. Am J Med (1985) 1.91
In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A (1996) 1.90
Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation (2001) 1.90
Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation (2001) 1.89
The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med (1998) 1.88
Cellular adhesion molecules and atherogenesis. Am J Med (1999) 1.88
Iron chelation improves endothelial function in patients with coronary artery disease. Circulation (2001) 1.88
Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation (2001) 1.86
Acute hypertriglyceridemia is associated with peripheral vasodilation and increased basal flow in healthy young adults. Am J Cardiol (2001) 1.85
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest (1991) 1.82
Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem (1997) 1.77
The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest (1996) 1.76
Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res (1995) 1.75
Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage. Free Radic Biol Med (2001) 1.71
US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol (2000) 1.71
Moving the retina: choroidal modulation of refractive state. Vision Res (1995) 1.70
Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab (2004) 1.66
Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J (1986) 1.64
Psychosocial factors impair vascular responses of coronary arteries. Circulation (1991) 1.64
Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology (2008) 1.63
Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 1.62
Serum adipocyte fatty acid-binding protein associated with ischemic stroke and early death. Neurology (2011) 1.60
Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med (1997) 1.58
Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res (1998) 1.58
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res (1989) 1.58
Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation (2000) 1.57
Body mass index and mortality in men: evaluating the shape of the association. Int J Obes (Lond) (2007) 1.57
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest (1985) 1.57
Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation (2000) 1.56
Time urgency and risk of non-fatal myocardial infarction. Int J Epidemiol (2001) 1.55
The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders. J Am Coll Cardiol (1991) 1.55
Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med (2001) 1.55
An overview of trials of cholesterol lowering and risk of stroke. Arch Intern Med (1995) 1.54
Peroxynitrite-induced rat colitis--a new model of colonic inflammation. Gastroenterology (1993) 1.53
In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest (1994) 1.53
Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem (2000) 1.52
Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation (1989) 1.52
Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg (1995) 1.51
Study of the distribution of non-point source pollution in the watershed of the Miyun Reservoir, Beijing, China. Water Sci Technol (2001) 1.49
c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J Biol Chem (2001) 1.49
Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest (1999) 1.49
A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells. Oncogene (2011) 1.49
Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol (1990) 1.47
Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study. Thorax (2008) 1.45
NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest (1993) 1.44
Homocysteine, oxidative stress, and vascular disease. Hosp Pract (1995) (1997) 1.44
A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group. Ann Epidemiol (1995) 1.44
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation (1990) 1.42
Nitroglycerin is preferable to diltiazem for prevention of coronary bypass conduit spasm. Ann Thorac Surg (2000) 1.41
Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ Res (1999) 1.41
Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation (1993) 1.40